1 “...Evidence-based synthesis program...”

2 Subjects: “...Carcinoma, Non-Small-Cell Lung / drug therapy...”

3 “...Evidence synthesis program...”

4 “... on increased incidences of C-cell adenoma or carcinoma in the thyroid gland and systemic mononuclear cell...”

5 “... on increased incidences of C-cell adenoma or carcinoma in the thyroid gland and systemic mononuclear cell...”

6

7

8

9 “... that mediate the cancer cell's ability to proliferate, grow, or evade cell death. Examples of targeted...”

10 “... that mediate the cancer cell's ability to proliferate, grow, or evade cell death. Examples of targeted...”

11 “... of strategies for evaluating and treating patients with a renal mass suspicious for renal cell carcinoma...”

12 “... of strategies for evaluating and treating patients with a renal mass suspicious for renal cell carcinoma...”

13 “... and Prescribing Safety (S.T.E.P.S.) program, patented by Celgene Corporation. The key questions for this review...”

14 “... and Prescribing Safety (S.T.E.P.S.) program, patented by Celgene Corporation. The key questions for this review...”